# Commission Decision of 27 July 2010 on the appointment of the members of the European Union Committee of Experts on Rare Diseases set up by Decision 2009/872/EC 2010/C 204/02, Division 2: Pharmaceutical industry

Extent: E+W+S+N.I.

2.1.
List in alphabetical order of representatives from the pharmaceutical industry
Last name
First name
Institute or organisation of affiliation
Hughes-Wilson
Wills
Genzyme
Loth
Kevin William
Celgene
Parker
Samantha
Orphan Europe
Valenta
Barbara
Baxter
2.2.
List in alphabetical order of alternates from the pharmaceutical industry
Last name
First name
Institute or organisation of affiliation
Fehervary
Andras C.
Novartis
Finck
Katia
Shire Human Genetic Therapies
Tellier
Zéra
LFB Biomédicaments
Zimmermann
Martine
Alexion Europe

---
Source: https://www.legislation.gov.uk/eudn/2010/728/annex/division/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2010-728/annex/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.